Trial Profile
INDUCTION OF DONOR-SPECIFIC TOLERANCE IN PATIENTS WITH LIVER TRANSPLANTATION WITH RECIPIENT PRE-TREATMENT WITH THYMOGLOBULINE AND MINIMAL POST-TRANSPLANT IMMUNOSUPPRESSION.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2012
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Everolimus; Tacrolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms THYTOTRA
- 28 Jun 2012 New trial record